Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

Archives of Neurology
Fumiko IrieLenore J Launer

Abstract

Diabetes and the apolipoprotein E epsilon4 allele (APOE epsilon4) increase the risk for Alzheimer disease (AD). We hypothesize that APOE epsilon4 may modify the risk for AD in individuals with diabetes. To examine the joint effect of type 2 diabetes and APOE epsilon4 on the risk of AD, AD with vascular dementia (mixed AD), and vascular dementia without AD. The Cardiovascular Health Study (CHS) Cognition Study (1992-2000) is a prospective study designed to identify all existing and new cases of dementia among study participants. Diagnoses were made according to international criteria for dementia and subtypes. There were 2547 dementia-free participants in the CHS Cognition Study cohort with complete information on APOE epsilon4 and type 2 diabetes status; among these, 411 new cases of dementia developed. Risk of dementia was estimated with a Cox proportional hazard model adjusted for age and other demographic and cardiovascular risk factors. Compared with those who had neither type 2 diabetes nor APOE epsilon4, those with both factors had a significantly higher risk of AD (hazard ratio, 4.58; 95% confidence interval, 2.18-9.65) and mixed AD (hazard ratio, 3.89; 95% confidence interval, 1.46-10.40). These data suggest that having...Continue Reading

Citations

Feb 15, 2014·Current Diabetes Reports·Anusha Jayaraman, Christian J Pike
Apr 22, 2014·The Journal of Nutritional Biochemistry·Mari TakaloMikko Hiltunen
Jun 19, 2012·Neurología : publicación oficial de la Sociedad Española de Neurología·J Campdelacreu
Dec 1, 2010·Nutrition Reviews·Greg M ColeSally A Frautschy
Apr 8, 2014·Diabetes & Metabolism·L BordierB Bauduceau
Dec 3, 2014·Clinics in Geriatric Medicine·Elizabeth Rose MayedaKristine Yaffe
Jul 1, 2009·Journal of Women's Health·Jodi R Godfrey, Nagwa S El-Badri
Nov 13, 2009·Dementia and Geriatric Cognitive Disorders·Erik J GiltayDaan Kromhout
Jan 13, 2012·Journal of Negative Results in Biomedicine·Hui-Chi ChengYen-Ching Chen
Feb 1, 2013·Neuroepidemiology·L L BarnesD A Bennett
Jun 17, 2010·Neurotoxicity Research·Peter RiedererEdna Grünblatt
Jul 28, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Jana PovovaVladimir Janout
Jun 23, 2010·Nature Reviews. Nephrology·Rory McQuillan, Sarbjit V Jassal
Sep 10, 2008·Epidemiologic Reviews·Nicola ColeyAlain Grand
Jul 11, 2012·International Journal of Alzheimer's Disease·Y WangK Henriksen
Feb 18, 2016·Acta Neuropathologica·Leon M TaiGuojun Bu
Aug 13, 2013·The International Journal of Neuroscience·Zhiyou CaiLiang-Jun Yan
Jan 13, 2015·Diabetes·Auriel A WilletteUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Dec 24, 2008·Journal of Neuropathology and Experimental Neurology·Carl JulienFrédéric Calon
Feb 4, 2014·Journal of Neuropathology and Experimental Neurology·Yuri I Arshavsky
Dec 14, 2011·Cardiovascular Psychiatry and Neurology·Lorraine Ba-TinNaji Tabet
Dec 18, 2013·Mechanisms of Ageing and Development·Barbara CaraccioloLaura Fratiglioni
Dec 19, 2014·Frontiers in Aging Neuroscience·Jane Maryam RondinaGeraldo Busatto Filho
Jun 21, 2016·Diabetes Research and Clinical Practice·Yi-Jing Sheen, Wayne H H Sheu
May 31, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Samo Ribarič
Aug 29, 2014·The Lancet. Diabetes & Endocrinology·Stefan L C GeijselaersGeert Jan Biessels
Jun 12, 2014·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Luiz K FerreiraGeraldo F Busatto
Sep 16, 2008·Biochimica Et Biophysica Acta·Peter T NelsonWilliam R Markesbery
Mar 19, 2014·Medicina clínica·Francesc FormigaManuel Pérez-Maraver
Dec 6, 2016·Journal of the American Geriatrics Society·Christiane ReitzJosé A Luchsinger
May 27, 2015·American Journal of Alzheimer's Disease and Other Dementias·Jessica M FoleyElizabeth C Leritz
Mar 21, 2015·American Journal of Alzheimer's Disease and Other Dementias·Yi-Hao PengChia-Hung Kao
Jul 6, 2010·American Journal of Alzheimer's Disease and Other Dementias·Olapeju G AderinwaleShaker A Mousa
Jun 7, 2017·Journal of Alzheimer's Disease : JAD·Kevin HuynhPeter J Meikle

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.